Research Article

Ginsenoside Rb1 Improves Cognitive Impairment Induced by Insulin Resistance through Cdk5/p35-NMDAR-IDE Pathway

Figure 4

Ginsenoside Rb1 inhibited the activity of Cdk5/p35 in vivo and increased the expression of NMDAR1 and IDE in the hippocampus (-10). Data are expressed as . (a) Ginsenoside Rb1 suppressed Cdk5/p35 activity in vivo. (b–d) Ginsenoside Rb1 unregulated NMDAR1 and IDE expression in the hippocampus of STZ-induced mice. , the model group vs. the control group; # and ##, the ginsenoside Rb1 group vs. the model group.
(a)
(b)
(c)
(d)